About
Jesper Gromada is a Venture Partner at Third Rock Ventures with experience as a pharmaceutical executive and drug discovery scientist. He has led multidisciplinary teams and directed programs across multiple disease areas, with responsibility for the development of more than 10 drug candidates and marketed drugs. His scientific work includes over 150 publications and 30 patent applications, along with established partnerships across academic and biopharmaceutical institutions.
Experience
- Third Rock VenturesVenture Partnercurrent2022 — presentBoston, Massachusetts, United States
- LarondeChief Scientific Officer2020 — 2022Cambridge, Massachusetts, United States
- Vertex PharmaceuticalsSite Head - Vertex Genetic Therapies2019 — 2020Boston
- Exonics TherapeuticsChief Scientific Officer2018 — 2019Greater Boston
- Regeneron PharmaceuticalsVP - Muscle and Metabolism Therapeutic Areas2012 — 2018
- NovartisExecutive Director2006 — 2012Cambridge, MA
- Eli Lilly and CompanyAssociate Director2000 — 2006Hamburg, Germany
- Novo NordiskResearch Scientist1995 — 2000Denmark
Education
- Københavns Universitet - University of CopenhagenPhD, Cell Biology1992 — 1995
- Københavns Universitet - University of CopenhagenDMSci, Physiology
Skills & more
Diabetes Research3Drug Discovery56Metabolic Diseases2Diabetes47Cell Biology23Biopharmaceuticals18Pharmacology17Therapeutics2Pharmaceuticals3Target Identification6Endocrinology7Research9
+12 more
MetabolismProtein ChemistryDrug DevelopmentIn VitroCellCell SignalingAssay DevelopmentPharmaceuticsMetabolism ResearchPharmaceutical IndustryIon ChannelsLaboratoryLanguages Danish · English · German
From Jesper's professional profile.
Same school
Also attended Københavns Universitet - University of Copenhagen77
Tommy AhlersFormer Danish Science Minister at Giant Ventures Global LlpClaus AnderssonGeneral Partner at Sunstone CapitalSten VerlandVenture Partner at Sunstone CapitalSophie Blomgren-HansenStudent Assistant at Sunstone CapitalTine LindgreenPrincipal at SEED Capital DenmarkAnne Cathrine WilhjelmAttorney, Partner at SEED Capital Denmark
+ 71 more
Shared employers
Also worked at Laronde3
Also worked at Vertex Pharmaceuticals19
Bruce SachsInvestor at CRV (Charles River Ventures)Stephen ChambersGeneral Partner at SOSVAlexandra CantleyManaging Partner at Polaris PartnersShwen GweeDigital Pharma Advisor at Excelerate Health VenturesSumia ShaikhHead of Platform at New York Life VenturesMegInvestor at Sanofi Ventures
+ 13 more
Also worked at Regeneron Pharmaceuticals15
David SchenkeinInvestor at GV (Google Ventures)Justin LiuVice President at Sapphire VenturesLisa PurcellInvestor at Third Rock VenturesMax KanevskyVenture Partner at Excelerate Health VenturesDhiren PatelDigital Pharma Advisor at Excelerate Health VenturesOdera UgwuInvestor at Alix Ventures
+ 9 more
Also worked at Novartis105
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesSteve TregayManaging General Partner at Mission Biocapital
+ 99 more
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures